DIAGNOS Inc. Stock OTC Markets

DGNOF

CA2524423068

IT Services & Consulting

Market Closed - OTC Markets Other stock markets 10:59:50 2026-07-23 EDT			5-day change	1st Jan Change
0.1666 ^USD	+3.90%		+3.09%	-37.06%

07-07	Diagnos Announces Warrants Extension	MT
06-18	DIAGNOS to Issue Shares for To Settle $125,000 of Debt	MT

Analysts' recommendations: DIAGNOS Inc.

25-10-08

Diagnos Passes Annual External Quality Audit Program

More recommendations

News in other languages: DIAGNOS Inc.

06-16	DIAGNOS dépose une demande de licence modifiée et mise à jour auprès de Santé Canada pour la plateforme du système CARA
06-05	Emerging Growth Research publie un rapport éclair sur DIAGNOS, mettant en lumière les catalyseurs réglementaires et le potentiel de commercialisation de la plateforme CARA AI
06-03	DIAGNOS présentera à la conférence Emerging Growth le 10 juin 2026
04-08	DIAGNOS fait le point sur les démarches réglementaires et de vente concernant CARA
04-01	DIAGNOS : 2026-04-01, DIAGNOS complète avec succès le processus de renouvellement d’enregistrement d’établissement auprès de la US-FDA – Télécharger le PDF

More news

Managers and Directors: DIAGNOS Inc.

Manager	Title	Age	Since
André Larente CEO	Chief Executive Officer	-	-
Marc-André Massue DFI	Director of Finance/CFO	-	2008-04-30
Yves-Stéphane Couture COO	Chief Operating Officer	-	2024-01-15

Director	Title	Age	Since
André Larente BRD	Director/Board Member	-	2000-09-20
Philippe Couillard CHM	Chairman	69	2025-10-29
Robert Dunn BRD	Director/Board Member	72	2020-09-27

More insiders

Other IT Services & Consulting

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DIAGNOS INC.	+3.90%	+3.09%	-	-	19.65M
IBM	+0.43%	-5.66%	-26.72%	+48.73%	194B
SNOWFLAKE INC.	-1.00%	-1.81%	+24.73%	+50.73%	91.89B
ACCENTURE PLC	-0.96%	-4.06%	-51.50%	-55.93%	84.9B
TATA CONSULTANCY SERVICES LTD.	+0.51%	-0.65%	-28.39%	-33.59%	83.8B
RELX PLC	+2.37%	+0.60%	-36.78%	-2.75%	56.97B
INFOSYS LIMITED	-0.62%	-5.07%	-32.95%	-22.12%	43.79B
NEC CORPORATION	+0.21%	-2.41%	+2.83%	+208.57%	34.32B
FUJITSU LIMITED	+1.08%	-0.58%	+0.89%	+78.45%	34.34B
HCL TECHNOLOGIES LIMITED	+2.11%	+5.57%	-15.67%	+14.21%	34.78B
Average	+1.36%	-1.67%	-18.17%	+31.81%	73.22B
Weighted average by Cap.	+1.07%	-2.59%	-20.67%	+23.95%

See all sector performances

Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change	Volume
26-07-23	US$0.1666	+3.90%	124,500
26-07-22	US$0.1604	+0.22%	98,000
26-07-21	US$0.1600	-0.99%	79,000
26-07-20	US$0.1616	+1.06%	182,801
26-07-17	US$0.1599	-1.05%	151,000

Delayed Quote OTC Markets

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Cap	27.69M 19.65M 17.28M 16.06M 14.77M 1.9B 28.19M 192M 74.89M 928M 73.78M 72.18M 3.22B	P/E 2025	-6.18x	P/E 2026	-6.51x
Enterprise Value	27.17M 19.28M 16.96M 15.75M 14.49M 1.87B 27.66M 188M 73.47M 911M 72.38M 70.81M 3.16B	EV / Sales 2025	293x	EV / Sales 2026	498x
Free-Float	95.78%	Yield 2025 *	-	Yield 2026	-

07-07	Diagnos Announces Warrants Extension	MT
06-18	DIAGNOS to Issue Shares for To Settle $125,000 of Debt	MT
06-16	Diagnos Inc Submits Modified And Updated Health Canada Licence Application For Cara System Platform	CI
06-16	Diagnos Submits Modified And Updated Application to Health Canada For CARA Platform	MT
06-11	DIAGNOS Inc. Reports Earnings Results for the Full Year Ended March 31, 2026	CI
06-10	DIAGNOS Inc. Auditor Raises 'Going Concern' Doubt	CI
04-08	Diagnos to submit future CARA version to FDA before end of Q3	RE
04-08	Diagnos Inc Provides Update on Cara Product Regulatory and Commercialization Activities	CI
04-01	Diagnos Renews FDA Medical Device Establishment Registration, Updates On CARA	MT
04-01	Diagnos Inc Successfully Completes Renewal Of US-FDA Medical Device Establishment Registration	CI
02-25	DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-04	Diagnos, ETS, Announce $1 Million Funding From Federal Govt to Advance AI in Retinal Image Analysis	MT
01-13	Diagnos Inc. Advances Regulatory Strategy for Cara in Key Markets: Updates on Health Canada, Fda, and Sfda Progress	CI

07-07	DIAGNOS to Extend the Exercise Period of Stock Warrants	GL
06-18	DIAGNOS Announces Shares for Debt Settlement	GL
06-16	DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform	GL
06-12	DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting	GL
06-05	Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform	GL

1 day	+3.90%
1 week	+3.09%
Current month	-4.91%
1 month	+8.18%
3 months	-7.29%
6 months	-28.37%
Current year	-37.06%

1 week	0.16	0.17
1 month	0.15	0.2
Current year	0.13	0.28
1 year	0.13	0.29
3 years	0.13	0.43
5 years	0.11	0.46
10 years	0.09	1.5

DIAGNOS Inc. Stock OTC Markets

Stocks

DGNOF

CA2524423068

IT Services & Consulting

Valuation: DIAGNOS Inc.

Chart: DIAGNOS Inc.

Latest news : DIAGNOS Inc.

Analysts' recommendations: DIAGNOS Inc.

Press Releases: DIAGNOS Inc.

News in other languages: DIAGNOS Inc.

Quotes and Performance

Course Extremes

Managers and Directors: DIAGNOS Inc.

Other IT Services & Consulting

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

	2025	2026
Net sales	104K 73.65K 64.78K 60.18K 55.35K 7.13M 106K 720K 281K 3.48M 277K 271K 12.07M	65.48K 46.46K 40.86K 37.96K 34.92K 4.5M 66.65K 454K 177K 2.19M 174K 171K 7.61M
Net income	-4.29M -3.04M -2.68M -2.49M -2.29M -295M -4.36M -29.72M -11.59M -144M -11.42M -11.17M -498M	-4.56M -3.23M -2.84M -2.64M -2.43M -313M -4.64M -31.58M -12.32M -153M -12.14M -11.87M -530M
Net Debt	-164K -116K -102K -94.91K -87.29K -11.25M -167K -1.13M -443K -5.49M -436K -427K -19.04M	-525K -373K -328K -304K -280K -36.09M -535K -3.64M -1.42M -17.6M -1.4M -1.37M -61.07M